Even in the pharmaceutical sector where product development times are long, categorising a research project as fundamental research, industrial research or precompetitive development activity is open to a wide range of interpretation. Particular account needs to be taken as regards the existing state-of-the-art technology and technology trends.
Nevertheless, the boundary conditions of the types of research and development that may benefit from State funding are clearly defined, and may be used to determine whether the R & D aid is compatible with the common market.
To qualify as 'fundamental research` (and eligible for up to 100 % funding) the work should not be linked to any industrial or commercial objective of any particular enterprise, and a wide dissemination of the results of the research must be guaranteed (in a time frame such that the whole industrial sector may benefit). The definition of 'precompetitive development activity` encompasses research activities (eligible for up to 25 % funding) up to and including the creation of an initial prototype, initial demonstration projects or pilot projects which cannot be converted or used for industrial applications or commercial exploitation; explicitly excluded are routine or periodic changes made to products, production lines, manufacturing processes, existing services and other operations in progress, even if such changes may represent improvements.